Challenges for Microbiome-based Drug Development
Cast as our enemies for much of modern medical history, bacteria are now emerging as potential treatments for a range...
AcuraBio and XING Technologies to manufacture rapid SARS-CoV-2 diagnostic kit
AcuraBio is pleased to announce they have been selected to partner with XING Technologies (Brisbane) to co-develop and manufacture a...
Luina Bio: We remain open to end Coronavirus together
We Improve lives by making drug development easier for our customers Our biopharmaceutical manufacturing facility (Darra, Australia) remains open during...
Luina Bio and Griffith University Position to Develop Coronavirus Vaccine
For Immediate Release Luina Bio and Griffith University Position to Develop Coronavirus Vaccine March 13 2020 Luina Bio is delighted...
Luina Bio COVID 19 response plan
Following the recent developments of the COVID 19 pandemic, the management team at Luina Bio has developed a series of...
Client Support Services Offered by Contract Manufacturers
By providing a professional, reliable and high quality service to its clients, Luina Bio ticks all the boxes when it...
Extracting and Purifying Natural Products
A leading Australian contract development and manufacturing organisation, Luina Bio offers a range of capabilities in natural products extraction, purification...
What is API Contract Manufacturing?
Partnering with the right contractor is one of the most critical decisions a pharmaceutical company can make The active pharmaceutical...
How Microbial Fermentation and Protein Biomanufacturing Works
Luina Bio’s manufacturing facility offers the latest fermentation technologies supported by world-renowned expertise in drug development and production Microbial...
